Phase 1, Healthy Subject, Safety, Tolerability and Pharmacokinetic Study of mGlu5 NAM HTL0014242

计划入组 71 人 · 首次发布于 2018 年 12 月 24 日

Pharmacokinetics and Side Effects of the mGlu5 Antagonist Fenobam in Adult Healthy Volunteers

计划入组 32 人 · 首次发布于 2013 年 3 月 7 日

PET Imaging Study to Evaluate the mGlu5r Occupancy Following ADX48621 (Dipraglurant) Administration

计划入组 12 人 · 首次发布于 2015 年 5 月 19 日

mGlu5 receptor positive allosteric modulators (Lundbeck)

mGluR5 NAMs (Addex)

mGluR5 PAMs (Janssen)

Indivior Advances GABAB Positive Allosteric Modulator Through IND-Enabling Studies for Substance Use Disorders

Addex GABAB PAM Candidate Shows Promising Anti-Cough Activity in Non-Human Primate Studies

Tempero Bio Secures $70M Series B to Advance Novel Addiction Treatment Through Phase 2 Trials